Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
| Status: | Archived |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2010 |
| End Date: | December 2011 |
Maraviroc Plus Darunavir/Ritonavir Study for Treatment-Naïve Patients Infected With R5-tropic HIV-1 Based on Enhanced Sensitivity Trofile
The objective of this study is to evaluate the safety and efficacy of a novel combination
antiretroviral therapy regimen consisting of maraviroc plus darunavir/ritonavir in
treatment-naive patients infected with R5-tropic HIV-1. The hypothesis is that in
treatment-naive subjects infected with R5-tropic HIV-1, combination antiretroviral therapy
with maraviroc plus darunavir/ritonavir is well tolerated and efficacious.
We found this trial at
5
sites
University of Miami Hospital The University of Miami changed the face of modern health care...
Click here to add this to my saved trials
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials